Clinical Trial Update: Temozolomide in Treating Patients With Recurrent Malignant Glioma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial of temozolomide for patients with recurrent malignant glioma and notes that the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED